In stressed HLE-B3 cells with AKT1 knockdown, AICAR reversed the improvement in ROS levels relative to before treatment.
In plain wordsIn cells with AKT1 knockdown, AICAR reversed the improvement in reactive oxygen levels compared with before treatment.
- Peptide
- AICAR (acadesine)
- Outcome
- IncreaseROS levels
- Study
humann: not reported in source
HLE-B3 cells with oxidative stress and AKT1 knockdown- Comparator
- Before AICAR treatment in AKT1-knockdown cells
- Outcome group
- Oxidative stress · Eye
- Studied dose
- Dose not stated
Source sentences
However, compared with the findings before AICAR treatment, these effects were antagonized after AICAR treatment in the si-AKT1 group (all P < 0.05).
5 context sentences(design, population, supporting numbers)
Compared to those in the si-NC group, these indicators were improved in the si-AKT1 group (all P < 0.05).
Compared with the control + si-NC group, the si-NC group exhibited elevated ROS and MDA levels, increased apoptosis rate, reduced SOD and GSH levels, downregulated Bcl-2, and upregulated Bax (all P < 0.05).
2) An oxidative stress model of lens epithelial cells was established by treating HLE-B3 cells with 200 μmol/L H2O2 for 24 h.
A si-AKT1 parallel group demonstrating significant changes in p-AMPK/AMPK values was selected and treated with Acadesine (AICAR), an AMPK agonist, to verify the role of the AMPK pathway.
Western blot was performed to determine Bcl-2 and Bax protein levels in the si-NC group, the control + si-NC group, and the si-AKT1 group before and after the administration of AICAR.